Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950168-03-000935
Filing Date
2003-03-26
Accepted
2003-03-26 14:05:16
Documents
6
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K DATED 12/31/2002 d10k.htm 10-K 1946619
3 CERTIFICATE OF INCORPORATION dex33.htm EX-3.3 5875
4 EMPLOYMENT AGREEMENT BETWEEN REGISTRANT & RICHARD D. BROUNSTEIN dex10125.htm EX-10.125 34129
5 LETTER AGREEMENT BETWEEN REGISTRANT & NANCY E. KATZ dex10126.htm EX-10.126 5889
6 LETTER AGREEMENT BETWEEN REGISTRANT & BRISTOL INVESTMENT FUND, LTD. dex10127.htm EX-10.127 11346
7 CONSENT OF KPMG LLP dex231.htm EX-23.1 3549
  Complete submission text file 0000950168-03-000935.txt   2009623
Mailing Address 1265 HARBOR BAY PKWY ALAMEDA CA 94502
Business Address 1265 HARBOR BAY PARKWAY ALAMEDA CA 94502- 5107495100
CALYPTE BIOMEDICAL CORP (Filer) CIK: 0000899426 (see all company filings)

EIN.: 061226727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20985 | Film No.: 03617848
SIC: 3826 Laboratory Analytical Instruments